Catalyst Wire Dossier Catalyst Wire Dossier

YP-P10 Ophthalmic Solution

· Yuyu Pharma, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for YP-P10 Ophthalmic Solution, covering 2024-07-30 to 2024-07-30. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2, Multi-center, Randomized, Double- Masked and Placebo-Controlled Study of YP-P10 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (ICECAP 1) [Phase 2]

See pricing